Good outcomes in ischemic stroke patients treated with intravenous thrombolysis despite regressing neurological symptoms

被引:68
作者
Baumann, CR [1 ]
Baumgartner, RW [1 ]
Gandjour, J [1 ]
von Büdingen, HC [1 ]
Siegel, AM [1 ]
Georgiadis, D [1 ]
机构
[1] Univ Zurich, Dept Neurol, Zurich, Switzerland
关键词
cerebrovascular disorder; thrombolysis;
D O I
10.1161/01.STR.0000217272.38455.a2
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background and Purpose-We evaluated the clinical course of 19 acute stroke patients with rapid early improvement of neurological deficit within the 3-hour window, treated with intravenous thrombolytics. Results-No patient demonstrated a neurological deterioration during hospitalization. National Institutes of Health Stroke Scale (NIHSS) scores at therapy decision and discharge were 5 (4 to 6) and 0.5 (0 to 1.5), respectively. At 3-month follow-up, 1 patient had died; in remaining patients, NIHSS was 0(0 to 1) and modified Rankin Scale 0.5 (0 to 1; <= 1 in 15 patients). Conclusions-Withholding of intravenous thrombolysis because of spontaneous early regression of neurological symptoms may not be justified.
引用
收藏
页码:1332 / 1333
页数:2
相关论文
共 7 条
[1]   Guidelines for the Early Management of Patients With Ischemic Stroke - 2005 guidelines update - A scientific statement from the Stroke Council of the American Heart Association/American Stroke Association [J].
Adams, H ;
Adams, R ;
Del Zoppo, G ;
Goldstein, LB .
STROKE, 2005, 36 (04) :916-923
[2]   CLASSIFICATION OF SUBTYPE OF ACUTE ISCHEMIC STROKE - DEFINITIONS FOR USE IN A MULTICENTER CLINICAL-TRIAL [J].
ADAMS, HP ;
BENDIXEN, BH ;
KAPPELLE, LJ ;
BILLER, J ;
LOVE, BB ;
GORDON, DL ;
MARSH, EE ;
KASE, CS ;
WOLF, PA ;
BABIKIAN, VL ;
LICATAGEHR, EE ;
ALLEN, N ;
BRASS, LM ;
FAYAD, PB ;
PAVALKIS, FJ ;
WEINBERGER, JM ;
TUHRIM, S ;
RUDOLPH, SH ;
HOROWITZ, DR ;
BITTON, A ;
MOHR, JP ;
SACCO, RL ;
CLAVIJO, M ;
ROSENBAUM, DM ;
SPARR, SA ;
KATZ, P ;
KLONOWSKI, E ;
CULEBRAS, A ;
CAREY, G ;
MARTIR, NI ;
FICARRA, C ;
HOGAN, EL ;
CARTER, T ;
GURECKI, P ;
MUNTZ, BK ;
RAMIREZLASSEPAS, M ;
TULLOCH, JW ;
QUINONES, MR ;
MENDEZ, M ;
ZHANG, SM ;
ALA, T ;
JOHNSTON, KC ;
ANDERSON, DC ;
TARREL, RM ;
NANCE, MA ;
BUDLIE, SR ;
DIERICH, M ;
HELGASON, CM ;
HIER, DB ;
SHAPIRO, RA .
STROKE, 1993, 24 (01) :35-41
[3]   Why are stroke patients excluded from TPA therapy? An analysis of patient eligibility [J].
Barber, PA ;
Zhang, J ;
Demchuk, AM ;
Hill, MD ;
Buchan, AM .
NEUROLOGY, 2001, 56 (08) :1015-1020
[4]   Reasons for exclusion from thrombolytic therapy following acute ischemic stroke [J].
Cocho, D ;
Belvís, R ;
Martí-Fàbregas, J ;
Molina-Porcel, L ;
Díaz-Manera, J ;
Aleu, A ;
Pagonabarraga, J ;
García-Bargo, D ;
Mauri, A ;
Martí-Vilalta, JL .
NEUROLOGY, 2005, 64 (04) :719-720
[5]   TISSUE-PLASMINOGEN ACTIVATOR FOR ACUTE ISCHEMIC STROKE [J].
MARLER, JR ;
BROTT, T ;
BRODERICK, J ;
KOTHARI, R ;
ODONOGHUE, M ;
BARSAN, W ;
TOMSICK, T ;
SPILKER, J ;
MILLER, R ;
SAUERBECK, L ;
JARRELL, J ;
KELLY, J ;
PERKINS, T ;
MCDONALD, T ;
RORICK, M ;
HICKEY, C ;
ARMITAGE, J ;
PERRY, C ;
THALINGER, K ;
RHUDE, R ;
SCHILL, J ;
BECKER, PS ;
HEATH, RS ;
ADAMS, D ;
REED, R ;
KLEI, M ;
HUGHES, S ;
ANTHONY, J ;
BAUDENDISTEL, D ;
ZADICOFF, C ;
RYMER, M ;
BETTINGER, I ;
LAUBINGER, P ;
SCHMERLER, M ;
MEIROSE, G ;
LYDEN, P ;
RAPP, K ;
BABCOCK, T ;
DAUM, P ;
PERSONA, D ;
BRODY, M ;
JACKSON, C ;
LEWIS, S ;
LISS, J ;
MAHDAVI, Z ;
ROTHROCK, J ;
TOM, T ;
ZWEIFLER, R ;
DUNFORD, J ;
ZIVIN, J .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 333 (24) :1581-1587
[6]   Thrombolytic therapy for acute ischemic stroke: Why the majority of patients remain ineligible for treatment [J].
O'Connor, RE ;
McGraw, P ;
Edelsohn, L .
ANNALS OF EMERGENCY MEDICINE, 1999, 33 (01) :9-14
[7]   Poor outcomes in patients who do not receive intravenous tissue plasminogen activator because of mild or improving ischemic stroke [J].
Smith, EE ;
Abdullah, AR ;
Petkovska, I ;
Rosenthal, E ;
Koroshetz, WJ ;
Schwamm, LH .
STROKE, 2005, 36 (11) :2497-2499